Rabies vaccine safety trial for ages 10 to 60
Part of Infections clinical trials.
This trial tests a freeze-dried rabies vaccine to see how safe it is when given on different schedules. It may be an option for people who need protection from rabies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 10 and 60 years old.
- You have not had a rabies vaccine or rabies treatment before.
- You have not been bitten or scratched by a dog or other mammal in the last year that broke the skin.
- You do not have a fever (temperature over 37.0°C) on the day you would get the vaccine.
- You are not pregnant, breastfeeding, or planning to have a baby during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new lyophilized rabies vaccine to see how well it works and how safe it is. It is for people who have not been vaccinated against rabies recently and have not been bitten or scratched by an animal that broke the skin in the past year.
This trial tests a new freeze-dried rabies vaccine grown in human cells. It aims to confirm the vaccine is safe and works well for people aged 10 to 60 who have not been vaccinated against rabies before and have not been recently bitten by a rabid animal. By joining, you help ensure that a reliable vaccine is available to protect against this serious disease.
This trial tests a new rabies vaccine to see if it's safe and effective. It's for people who haven't been vaccinated against rabies or been bitten by a rabies-risk animal recently.
This trial tests different doses of a rabies vaccine to see how well they protect against rabies and how safe they are. It's for healthy adults who may need rabies protection, for example after an animal bite or as routine prevention.
This study tests a new rabies vaccine given before any exposure to the virus, to help prevent infection. It aims to see if the vaccine is safe and creates a strong immune response in healthy people.
This trial tests a new rabies-prevention medicine made in a lab. It is for healthy people, not those who have been bitten, and aims to see if the injection is safe and how the body handles it.
Hear when a new RabiesPrevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.